Pham Minh Quan

Dr. Pham Minh Quan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KTKhai Quang Tran
Khai Quang Tran
TNThuy Thi Dieu Nguyen
Thuy Thi Dieu Nguyen
VPVan Hung Hung Pham
Van Hung Hung Pham
PQPham Minh Quan
Pham Minh Quan
HTHung Do Tran
Hung Do Tran
In recent years, the pathogenic role and antibiotic resistance of methicillin-resistant Staphylococcus aureus (MRSA) strains causing severe community-acquired pneumonia (CAP) have received increasing attention in clinical practice. The aim of this study was to determine the rate of isolates of MRSA strains causing severe CAP in children and to assess their level of antibiotic resistance. The study design was cross-sectional. Children with severe CAP were sampled by nasopharyngeal aspiration for the culture, isolation, and identification of MRSA. Antimicrobial susceptibility testing was performed using the gradient diffusion method to determine the minimum inhibitory concentration (MIC) of antibiotics. Results: MRSA was identified as the second leading cause of severe CAP in Vietnamese children. The rate of isolates of S. aureus was 41/239 (17.5%), of which most were MRSA, at 32/41 (78.0%). MRSA strains were completely non-susceptible to penicillin (100%), more resistant to clindamycin and erythromycin, less sensitive to ciprofloxacin and levofloxacin, and fully susceptible to vancomycin and linezolid, with a 32-fold decreased MIC90 for vancomycin (0.5 mg/L) and a 2-fold decreased MIC90 for linezolid (4 mg/L). Therefore, vancomycin and linezolid may be appropriate options for severe CAP identified by MRSA.

30 June 2025 in Archives of Pediatric Infectious Diseases
Verified
Journal Article
Open access
KTKhai Quang Tran
Khai Quang Tran
TLTrung Quoc Ly
Trung Quoc Ly
TLThu Thi Kim Le
Thu Thi Kim Le
LPLong Duy Phun
Long Duy Phun
TPTuyen Nguyen Kim Pham
Tuyen Nguyen Kim Pham
PQPham Minh Quan
Pham Minh Quan
Background: The prevalence of invasive Haemophilus influenzae type b (Hib) disease—especially community-acquired pneumonia (CAP)—has significantly decreased due to the widespread use of Hib conjugate vaccines. Non-typeable H. influenzae (NTHi) has since emerged as the predominant etiological agent of infections across various age groups in many countries, drawing increasing attention. Objectives: This study aimed to determine the prevalence of NTHi infection in children with CAP and to compare the clinical and laboratory characteristics of children with NTHi-associated versus other agent-associated CAP. Methods: This cross-sectional study included 336 children with CAP admitted to Can Tho Children's Hospital, Vietnam, between June 2020 and June 2022. Consecutive eligible patients were enrolled to minimize selection bias. Nasotracheal aspiration samples were collected and analyzed using real-time polymerase chain reaction (PCR) to detect the presence of 70 microbial agents. Results: No cases of Hib infection were identified. The NTHi was the second most common bacterial agent causing childhood CAP, with a prevalence of 22.9%. Most cases (96.1%) involved co-infections, primarily bacterial (44.2%). The most common co-infection with NTHi was Streptococcus pneumoniae (56/77; 72.7%); only 3 of 77 children (3.9%) had CAP due to NTHi alone. Compared to those with other agent-associated CAP, children with NTHi-associated CAP experienced less tachypnea (81.8% vs. 90.3%) and more diarrhea (20.8% vs. 12.4%), along with higher white blood cell (WBC) counts (median: 15.1 G/L vs. 13.4 G/L) and C-reactive protein (CRP) levels (median: 14.9 mg/L vs. 11.0 mg/L) (P < 0.05). In multivariate logistic regression analysis, only two factors were independently associated with NTHi-associated CAP: reduced tachypnea (OR = 2.21; 95% CI: 1.07 - 4.59) and elevated WBC count (OR = 1.05; 95% CI: 1.00 - 1.10). Conclusions: The NTHi has replaced Hib as a leading cause of CAP in children. Patients presenting with less tachypnea and elevated WBC counts are more likely to have NTHi-associated CAP.